Cargando…

Circulating Microbial Cell-Free DNA in Health and Disease

Human blood contains low biomass of circulating microbial cell-free DNA (cfmDNA) that predominantly originates from bacteria. Numerous studies have detected circulating cfmDNA in patients with infectious and non-infectious diseases, and in healthy individuals. Remarkable differences were found in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pietrzak, Bernadeta, Kawacka, Iwona, Olejnik-Schmidt, Agnieszka, Schmidt, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917616/ https://www.ncbi.nlm.nih.gov/pubmed/36769374 http://dx.doi.org/10.3390/ijms24033051

Ejemplares similares

Listeria monocytogenes Isolates from Meat Products and Processing Environment in Poland Are Sensitive to Commonly Used Antibiotics, with Rare Cases of Reduced Sensitivity to Ciprofloxacin
por: Kawacka, Iwona, et al.
Publicado: (2023)

Nonhemolytic Listeria monocytogenes—Prevalence Rate, Reasons Underlying Atypical Phenotype, and Methods for Accurate Hemolysis Assessment
por: Kawacka, Iwona, et al.
Publicado: (2022)

Secretory IgA in Intestinal Mucosal Secretions as an Adaptive Barrier against Microbial Cells
por: Pietrzak, Bernadeta, et al.
Publicado: (2020)

Effectiveness of Phage-Based Inhibition of Listeria monocytogenes in Food Products and Food Processing Environments
por: Kawacka, Iwona, et al.
Publicado: (2020)

Natural Plant-Derived Chemical Compounds as Listeria monocytogenes Inhibitors In Vitro and in Food Model Systems
por: Kawacka, Iwona, et al.
Publicado: (2020)

A Clinical Outcome of the Anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition
por: Pietrzak, Bernadeta, et al.
Publicado: (2022)

The Tumor and Host Immune Signature, and the Gut Microbiota as Predictive Biomarkers for Immune Checkpoint Inhibitor Response in Melanoma Patients
por: Tomela, Katarzyna, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy
por: Tomela, Katarzyna, et al.
Publicado: (2023)

Emerging Evidence on Membrane Estrogen Receptors as Novel Therapeutic Targets for Central Nervous System Pathologies
por: Wnuk, Agnieszka, et al.
Publicado: (2023)

Pneumocystis pneumonia and rheumatic disease: diagnostic potential of circulating microbial cell-free DNA sequencing
por: Li, Jia, et al.
Publicado: (2021)

Cell-free circulating tumor DNA in cancer
por: Qin, Zhen, et al.
Publicado: (2016)

Life and death of circulating cell-free DNA
por: Kustanovich, Anatoli, et al.
Publicado: (2019)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019)

Orphan nuclear hormone receptor NR4A1 interacts with HPV16 E2 regulatory protein
por: Olejnik-Schmidt, Agnieszka K., et al.
Publicado: (2006)

Circulating Cell-Free Tumour DNA in the Management of Cancer
por: Francis, Glenn, et al.
Publicado: (2015)

Bioinformatics Analysis for Circulating Cell-Free DNA in Cancer
por: Huang, Chiang-Ching, et al.
Publicado: (2019)

Circulating cell-free DNA for cancer early detection
por: Gao, Qiang, et al.
Publicado: (2022)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
por: Cheng, Xianliang, et al.
Publicado: (2017)

Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016)

Circulating, cell-free DNA as a marker for exercise load in intermittent sports
por: Haller, Nils, et al.
Publicado: (2018)

Circulating Free DNA and Its Emerging Role in Autoimmune Diseases
por: Mondelo-Macía, Patricia, et al.
Publicado: (2021)

Liquid biopsy for infectious diseases: a focus on microbial cell-free DNA sequencing
por: Han, Dongsheng, et al.
Publicado: (2020)

Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
por: Yu, Ming, et al.
Publicado: (2021)

Selective Targeting of Non-nuclear Estrogen Receptors with PaPE-1 as a New Treatment Strategy for Alzheimer’s Disease
por: Wnuk, Agnieszka, et al.
Publicado: (2020)

Diagnostic and Therapeutic Potential of Circulating-Free DNA and Cell-Free RNA in Cancer Management
por: Hassan, Sadia, et al.
Publicado: (2022)

Circulating microbial cell–free DNA is increased during neutropenia after hematopoietic stem cell transplantation
por: Blair, Lily M., et al.
Publicado: (2023)

Expression of bacteriocin divercin AS7 in Escherichia coli and its functional analysis
por: Olejnik-Schmidt, Agnieszka K., et al.
Publicado: (2013)

Circulating cell-free DNA in health and disease — the relationship to health behaviours, ageing phenotypes and metabolomics
por: Kananen, Laura, et al.
Publicado: (2022)

Circulating Cell-Free DNA Levels in Psychiatric Diseases: A Systematic Review and Meta-Analysis
por: Melamud, Mark M., et al.
Publicado: (2023)

The role of circulating cell-free DNA as an inflammatory mediator after stroke
por: Roth, Stefan, et al.
Publicado: (2023)

Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review
por: Vymetalkova, Veronika, et al.
Publicado: (2018)

Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer
por: Jaworski, Jedrzej J., et al.
Publicado: (2020)

Posttreatment with Ospemifene Attenuates Hypoxia- and Ischemia-Induced Apoptosis in Primary Neuronal Cells via Selective Modulation of Estrogen Receptors
por: Pietrzak, Bernadeta A., et al.
Publicado: (2023)

Impact of Circulating Cell-Free DNA (cfDNA) as a Biomarker of the Development and Evolution of Periodontitis
por: Viglianisi, Gaia, et al.
Publicado: (2023)

Post-Treatment with Amorfrutin B Evokes PPARγ-Mediated Neuroprotection against Hypoxia and Ischemia
por: Wnuk, Agnieszka, et al.
Publicado: (2021)

Circulating Cell-Free DNA in Inflammatory Bowel Disease: Liquid Biopsies with Mechanistic and Translational Implications
por: Chuah, Cher Shiong, et al.
Publicado: (2023)

The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients
por: Elshimali, Yahya I., et al.
Publicado: (2013)

Kinetics of circulating cell-free DNA for biomedical applications: critical appraisal of the literature
por: Khier, Sonia, et al.
Publicado: (2018)

Guidelines for pre-analytical conditions for assessing the methylation of circulating cell-free DNA
por: Kerachian, Mohammad Amin, et al.
Publicado: (2021)

Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision Medicine
por: Francini, Edoardo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fmmbtg7lluet6hd52n8k4vnr39